Information Journal Paper
APA:
CopyZINMAN, B., FULCHER, G., & RAO, P.V.. (2011). INSULIN DEGLUDEC, AN ULTRA-LONG-ACTING BASAL INSULIN, ONCE A DAY OR THREE TIMES A WEEK VERSUS INSULIN GLARGINE ONCE A DAY IN PATIENTS WITH TYPE 2 DIABETES: A 16-WEEK, RANDOMISED, OPENLABEL, PHASE 2 TRIAL. LANCET, 377(9769), 924-931. SID. https://sid.ir/paper/632559/en
Vancouver:
CopyZINMAN B., FULCHER G., RAO P.V.. INSULIN DEGLUDEC, AN ULTRA-LONG-ACTING BASAL INSULIN, ONCE A DAY OR THREE TIMES A WEEK VERSUS INSULIN GLARGINE ONCE A DAY IN PATIENTS WITH TYPE 2 DIABETES: A 16-WEEK, RANDOMISED, OPENLABEL, PHASE 2 TRIAL. LANCET[Internet]. 2011;377(9769):924-931. Available from: https://sid.ir/paper/632559/en
IEEE:
CopyB. ZINMAN, G. FULCHER, and P.V. RAO, “INSULIN DEGLUDEC, AN ULTRA-LONG-ACTING BASAL INSULIN, ONCE A DAY OR THREE TIMES A WEEK VERSUS INSULIN GLARGINE ONCE A DAY IN PATIENTS WITH TYPE 2 DIABETES: A 16-WEEK, RANDOMISED, OPENLABEL, PHASE 2 TRIAL,” LANCET, vol. 377, no. 9769, pp. 924–931, 2011, [Online]. Available: https://sid.ir/paper/632559/en